Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Catarina Schiborn"'
Autor:
Catarina Schiborn, Tilman Kühn, Kristin Mühlenbruch, Olga Kuxhaus, Cornelia Weikert, Andreas Fritsche, Rudolf Kaaks, Matthias B. Schulze
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Inclusion of clinical parameters limits the application of most cardiovascular disease (CVD) prediction models to clinical settings. We developed and externally validated a non-clinical CVD risk score with a clinical extension and compared t
Externí odkaz:
https://doaj.org/article/4b8f180ee28a4b43a2f861d78d22db1b
Autor:
Catarina Schiborn, Daniela Weber, Tilman Grune, Ronald Biemann, Susanne Jäger, Natascha Neu, Marie Müller von Blumencron, Andreas Fritsche, Cornelia Weikert, Matthias B. Schulze, Clemens Wittenbecher
Publikováno v:
Circulation research, 131(7):637-649
Background: Despite mechanistic studies linking retinol and RBP4 (retinol binding protein 4) to the pathogenesis of cardiovascular diseases (CVD) and type 2 diabetes (T2D), epidemiological evidence is still conflicting. We investigated whether confli
Autor:
Zuzana Špacírová, Stephen Kaptoge, Leticia García-Mochón, Miguel Rodríguez Barranco, María José Sánchez Pérez, Nicola P. Bondonno, Anne Tjønneland, Elisabete Weiderpass, Sara Grioni, Jaime Espín, Carlotta Sacerdote, Catarina Schiborn, Giovanna Masala, Sandra M. Colorado-Yohar, Lois Kim, Karel G. M. Moons, Gunnar Engström, Matthias B. Schulze, Léa Bresson, Concepción Moreno-Iribas, David Epstein
The objective of this article was to assess the cost-effectiveness of screening strategies for cardiovascular diseases (CVD). A decision analytic model was constructed to estimate the costs and benefits of one-off screening strategies differentiated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0073684fcd7e4b7ca4a5551cd881c1fe
https://www.repository.cam.ac.uk/handle/1810/342296
https://www.repository.cam.ac.uk/handle/1810/342296
Autor:
Anna Birukov, Branimir Plavša, Fabian Eichelmann, Olga Kuxhaus, Rosangela Akemi Hoshi, Najda Rudman, Tamara Štambuk, Irena Trbojević-Akmačić, Catarina Schiborn, Jakub Morze, Matea Mihelčić, Ana Cindrić, Yanyan Liu, Olga Demler, Markus Perola, Samia Mora, Matthias B. Schulze, Gordan Lauc, Clemens Wittenbecher
OBJECTIVE N-glycosylation is a functional posttranslational modification of immunoglobulins (Igs). We hypothesized that specific IgG N-glycans are associated with incident type 2 diabetes and cardiovascular disease (CVD). RESEARCH DESIGN AND METHODS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25030b133b3aebc33e55edd1a2b31df9
https://doi.org/10.2337/figshare.20670123.v1
https://doi.org/10.2337/figshare.20670123.v1
Autor:
Catarina Schiborn, Rebecca Paprott, Christin Heidemann, Tilman Kühn, Andreas Fritsche, Rudolf Kaaks, Matthias B. Schulze
Publikováno v:
Dtsch Arztebl Int
Schiborn, C, Paprott, R, Heidemann, C, Kühn, T, Fritsche, A, Kaaks, R & Schulze, M B 2022, ' German diabetes risk score for the determination of the individual type 2 diabetes risk. 10-year prediction and external validations ', Deutsches Arzteblatt international, vol. 119, pp. 651-657 . https://doi.org/10.3238/arztebl.m2022.0268
Schiborn, C, Paprott, R, Heidemann, C, Kühn, T, Fritsche, A, Kaaks, R & Schulze, M B 2022, ' German diabetes risk score for the determination of the individual type 2 diabetes risk. 10-year prediction and external validations ', Deutsches Arzteblatt international, vol. 119, pp. 651-657 . https://doi.org/10.3238/arztebl.m2022.0268
BACKGROUND: The German Diabetes Risk Score (GDRS) currently enables prediction of the individual risk of developing type 2 diabetes (T2D) within five years. The aim of this study is to extend the prediction period of the GDRS, including its non-clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1eb01c1972934e2bf5e03855b4aaaf5
https://europepmc.org/articles/PMC9811545/
https://europepmc.org/articles/PMC9811545/
Autor:
Matthias B. Schulze, Catarina Schiborn
Publikováno v:
Der Diabetologe. 16:226-233
Risikoscores werden zur Identifizierung von Hochrisikopersonen fur Typ-2-Diabetes (T2DM) eingesetzt, die von Praventionsmasnahmen profitieren. Der DIfE – DEUTSCHER DIABETES-RISIKO-TEST® (DRT [DIfE: Deutsches Institut fur Ernahrungsforschung Potsda
Autor:
Catarina Schiborn, Matthias B. Schulze
Publikováno v:
Diabetologia
Individuals with diabetes face higher risks for macro- and microvascular complications than their non-diabetic counterparts. The concept of precision medicine in diabetes aims to optimise treatment decisions for individual patients to reduce the risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3a3f8c122315e17cfffebaa8c12af3
https://repository.publisso.de/resource/frl:6434495
https://repository.publisso.de/resource/frl:6434495
Autor:
Trasias Mukama, Renée Turzanski Fortner, Verena Katzke, Lucas Cory Hynes, Agnese Petrera, Stefanie M. Hauck, Theron Johnson, Matthias Schulze, Catarina Schiborn, Agnetha Linn Rostgaard-Hansen, Anne Tjønneland, Kim Overvad, María José Sánchez Pérez, Marta Crous-Bou, María-Dolores Chirlaque, Pilar Amiano, Eva Ardanaz, Eleanor L. Watts, Ruth C. Travis, Carlotta Sacerdote, Sara Grioni, Giovanna Masala, Simona Signoriello, Rosario Tumino, Inger T. Gram, Torkjel M. Sandanger, Hanna Sartor, Eva Lundin, Annika Idahl, Alicia K. Heath, Laure Dossus, Elisabete Weiderpass, Rudolf Kaaks
Publikováno v:
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Br. J. Cancer (2022)
Mukama, T, Fortner, R T, Katzke, V, Hynes, L C, Petrera, A, Hauck, S M, Johnson, T, Schulze, M, Schiborn, C, Rostgaard-Hansen, A L, Tjønneland, A, Overvad, K, Pérez, M J S, Crous-Bou, M, Chirlaque, M-D, Amiano, P, Ardanaz, E, Watts, E L, Travis, R C, Sacerdote, C, Grioni, S, Masala, G, Signoriello, S, Tumino, R, Gram, I T, Sandanger, T M, Sartor, H, Lundin, E, Idahl, A, Heath, A K, Dossus, L, Weiderpass, E & Kaaks, R 2022, ' Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer ', British Journal of Cancer, vol. 126, no. 9, pp. 1301-1309 . https://doi.org/10.1038/s41416-021-01697-z
instname
Br. J. Cancer (2022)
Mukama, T, Fortner, R T, Katzke, V, Hynes, L C, Petrera, A, Hauck, S M, Johnson, T, Schulze, M, Schiborn, C, Rostgaard-Hansen, A L, Tjønneland, A, Overvad, K, Pérez, M J S, Crous-Bou, M, Chirlaque, M-D, Amiano, P, Ardanaz, E, Watts, E L, Travis, R C, Sacerdote, C, Grioni, S, Masala, G, Signoriello, S, Tumino, R, Gram, I T, Sandanger, T M, Sartor, H, Lundin, E, Idahl, A, Heath, A K, Dossus, L, Weiderpass, E & Kaaks, R 2022, ' Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer ', British Journal of Cancer, vol. 126, no. 9, pp. 1301-1309 . https://doi.org/10.1038/s41416-021-01697-z
The coordination of EPIC is financially supported by International Agency for Research on Cancer (IARC) and also by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London-, which has additional infrastructu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f10515d606c6272f749370eb43d0ac30
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-191667
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-191667
Autor:
Olga Kuxhaus, Rudolf Kaaks, Matthias B. Schulze, Andreas Fritsche, Kristin Mühlenbruch, Catarina Schiborn, Tilman Kühn, Cornelia Weikert
Publikováno v:
Scientific Reports
Scientific reports, 11(1):19609
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Sci. Rep. 11:19609 (2021)
Scientific reports, 11(1):19609
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Sci. Rep. 11:19609 (2021)
Inclusion of clinical parameters limits the application of most cardiovascular disease (CVD) prediction models to clinical settings. We developed and externally validated a non-clinical CVD risk score with a clinical extension and compared the perfor
Autor:
Olga Kuxhaus, Clemens Wittenbecher, Tamara Štambuk, Olga Gornik, Heiner Boeing, Najda Rudman, Jerko Štambuk, Matthias B. Schulze, Stefan Dietrich, Frano Vučković, Catarina Schiborn, Gordan Lauc, Markus Perola, Dario Rahelić
Publikováno v:
Diabetes Care
OBJECTIVE Plasma protein N-glycan profiling integrates information on enzymatic protein glycosylation, which is a highly controlled ubiquitous posttranslational modification. Here we investigate the ability of the plasma N-glycome to predict incidenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c9434fd596ed354f151b18b4e7db736
https://www.bib.irb.hr/1167065
https://www.bib.irb.hr/1167065